Delivery Order SPE2DB22D3016-SPE2DB25FBJS6
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,621.52 by the Defense Logistics Agency on August 11, 2025, for Freestyle Libre 3 Plus Sensors. The contract employs firm fixed pricing and is scheduled for completion by August 12, 2025. This award was made on a competitive basis with no set-aside designation. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $4,175.12 from the Defense Logistics Agency (DLA) on September 15, 2025, for FreeStyle Libre 3 sensors. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 16, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical supply distributor for...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of FreeStyle Libre 3 glucose monitoring sensors. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $11,677.44 and is set to conclude by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,301.71 by the Defense Logistics Agency for Freestyle Libre 3 Plus Sensors. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 22, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of FreeStyle Libre 3 Sensors, with a ceiling value of $1,001.04. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 6, 2025. This award was made through open competition with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of FreeStyle Libre 3 Sensors, with a contract ceiling value of $15,521.61. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the federal government's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,967.88 by the Defense Logistics Agency (DLA) on September 17, 2025, with completion expected by September 18, 2025. The contract covers the supply of FreeStyle Libre 3 Plus Sensors, continuous glucose monitoring devices used for diabetes management. This delivery order is classified as firm fixed price with no set-aside designation, indicating competitive award. The place of performance is the contractor's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,072.32 by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Freestyle Libre 3 Plus Sensors. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 22, 2025, and represents a continuation of AmerisourceBergen's extensive relationship with DLA's medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of FreeStyle Libre 3 Plus Sensors, valued at $1,072.32 with a completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,002.08 in Freestyle Libre 3 sensors, with a completion date of September 19, 2025. This competitively awarded contract, issued on September 18, 2025, carries no set-aside designation and operates under firm fixed-price terms. The delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJS6Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of FreeStyle Libre 3 Sensors with a ceiling value of $4,004.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by September 18, 2025, with performance to occur at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical devices to support military healthcare programs worldwide. FreeStyle Libre 3 Sensors are continuous glucose monitoring devices used in diabetes management, consistent with the company's portfolio of specialty medications and medical supplies delivered to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/17/25 |